Olivier Le Rouzic
Overview
Explore the profile of Olivier Le Rouzic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
415
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Grosbois J, Detree A, Pierache A, Bautin N, Perez T, Wallaert B, et al.
Int J Chron Obstruct Pulmon Dis
. 2023 Mar;
18:155-167.
PMID: 36860514
Background: Cardiovascular and metabolic comorbidities in chronic obstructive pulmonary disease (COPD) are associated with higher symptoms burden. Few center-based studies have evaluated the impact of these comorbidities on short-term pulmonary...
12.
Grosbois J, Gephine S, Kyheng M, Le Rouzic O, Chenivesse C
ERJ Open Res
. 2023 Jan;
8(4).
PMID: 36655219
Objectives: The aim of this study was to evaluate the effects of a home-based pulmonary rehabilitation (PR) programme on anxiety and depressive symptoms, general fatigue and burden in informal caregivers...
13.
Stabler S, Lamblin C, Gaillard S, Just N, Mihailescu M, Viget N, et al.
Clin Infect Dis
. 2022 Oct;
76(5):800-808.
PMID: 36285530
Background: Primary immunodeficiencies (PIDs) in adults are mainly revealed by recurrent and/or severe bacterial infections. The objective of this study was to evaluate a systematic research strategy of PIDs in...
14.
Cook N, Criner G, Burgel P, Mycock K, Gardner T, Mellor P, et al.
ERJ Open Res
. 2022 Jun;
8(2).
PMID: 35734770
Introduction: This patient preference study sought to quantify the preferences of people living with COPD regarding symptom improvement in the UK, USA, France, Australia and Japan. Methods: The inclusion criteria...
15.
Nuytten A, Prevotat A, Le Rouzic O, Dekemp J, Gilliot S, Gautier S, et al.
Therapie
. 2022 May;
77(6):743-745.
PMID: 35606190
No abstract available.
16.
Grosbois J, Gephine S, Kyheng M, Henguelle J, Le Rouzic O, Saey D, et al.
BMJ Open Respir Res
. 2022 Jan;
9(1).
PMID: 35078826
Background: Dyspnoea is a multidimensional experience of breathing discomfort, but its affective dimension is unfrequently assessed in people with chronic obstructive pulmonary disease (COPD). We evaluated the effectiveness of a...
17.
Gantois N, Lesaffre A, Durand-Joly I, Bautin N, Le Rouzic O, Nseir S, et al.
Med Mycol
. 2021 Nov;
60(1).
PMID: 34734270
Lay Summary: Chronic obstructive pulmonary disease patients tend to be more frequently colonized by Pneumocystis during exacerbation (19.0%) than at stable state (10.7%). Factors associated with colonization include lower BMI,...
18.
Grosbois J, Gephine S, Le Rouzic O, Chenivesse C
Respir Med Res
. 2021 Jun;
80:100846.
PMID: 34153703
No abstract available.
19.
Zysman M, Deslee G, Perez T, Burgel P, Le Rouzic O, Brinchault-Rabin G, et al.
Int J Chron Obstruct Pulmon Dis
. 2021 May;
16:1275-1284.
PMID: 34007166
Background: Chronic respiratory failure may occur as a consequence of chronic obstructive pulmonary disease (COPD) and is associated with significant morbidity and mortality. Hypoxemia is determined by underlying disease characteristics...
20.
Valentin V, Bervar J, Vincent-Delorme C, Smol T, Wemeau L, Remy M, et al.
Chest
. 2021 Mar;
159(3):e131-e135.
PMID: 33678279
Emphysema is a chronic respiratory disorder characterized by destruction of alveoli, usually due to cigarette smoking or exposure to noxious particles or gases. Dysfunction of proteins that are involved in...